| Q36643419 | 100 years and counting: prospects for defeating Alzheimer's disease |
| Q34005558 | A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder |
| Q36452227 | APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis |
| Q46000890 | APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. |
| Q30493543 | Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease |
| Q22252311 | Alzheimer mechanisms and therapeutic strategies |
| Q35693893 | Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites |
| Q53317692 | Amyloid precursor protein gene (APP) variation in late-onset Alzheimer's disease. |
| Q39006798 | ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion |
| Q36967985 | Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia |
| Q37315301 | Contemplating effects of genomic structural variation |
| Q22241945 | Current Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic Approaches |
| Q33871345 | Current status on Alzheimer disease molecular genetics: from past, to present, to future |
| Q37872024 | DNA methylation in neurodegenerative disorders: a missing link between genome and environment? |
| Q37622647 | F-box only protein 2 (Fbxo2) regulates amyloid precursor protein levels and processing |
| Q42642426 | Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients |
| Q35094704 | Genetics of Vascular Dementia |
| Q38027808 | Genetics of dementia: update and guidelines for the clinician |
| Q34874591 | High glucose promotes Aβ production by inhibiting APP degradation |
| Q48302187 | Marginal vitamin A deficiency facilitates Alzheimer's pathogenesis |
| Q39054244 | Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice |
| Q42426890 | MicroRNAs can regulate human APP levels. |
| Q41665323 | Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease |
| Q34584517 | Modulation of amyloid precursor protein expression reduces β-amyloid deposition in a mouse model. |
| Q37209771 | Molecular genetics of Alzheimer's disease: an update |
| Q26750717 | Molecular genetics of early-onset Alzheimer's disease revisited |
| Q33575683 | Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma |
| Q34052418 | Next-generation DNA sequencing-based assay for measuring allelic expression imbalance (AEI) of candidate neuropsychiatric disorder genes in human brain |
| Q40863954 | Opposite Dysregulation of Fragile-X Mental Retardation Protein and Heteronuclear Ribonucleoprotein C Protein Associates with Enhanced APP Translation in Alzheimer Disease. |
| Q34067152 | Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice |
| Q34014237 | Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials |
| Q33830518 | Recent insights into the molecular genetics of dementia |
| Q64069671 | Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer's disease and its mechanism |
| Q35883202 | Role of common and rare APP DNA sequence variants in Alzheimer disease |
| Q59069488 | Somatic APP gene recombination in Alzheimer’s disease and normal neurons |
| Q37704614 | The clinical context of copy number variation in the human genome |
| Q50345695 | The genetic architecture of autism spectrum disorders (ASDs) and the potential importance of common regulatory genetic variants. |
| Q81651107 | The genetics of Alzheimer's disease |
| Q33995527 | Understanding microRNAs in neurodegeneration |
| Q47431150 | Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease. |